Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.96 USD | -2.49% | +5.38% | -1.01% |
Financials (USD)
Sales 2024 * | 20.8M | Sales 2025 * | 19.22M | Capitalization | 159M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -34M | EV / Sales 2024 * | 7.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.3 x |
P/E ratio 2024 * |
-4.4
x | P/E ratio 2025 * |
-4.78
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on ProQR Therapeutics N.V.
1 day | -2.49% | ||
1 week | +5.38% | ||
Current month | -14.41% | ||
1 month | -17.99% | ||
3 months | -6.22% | ||
6 months | +63.33% | ||
Current year | -1.01% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel de Boer
CEO | Chief Executive Officer | 41 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Jurriaan Dekkers
DFI | Director of Finance/CFO | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Valerio
FOU | Founder | 67 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Alison Lawton
BRD | Director/Board Member | 62 | 14-09-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.96 | -2.49% | 238,956 |
24-04-24 | 2.01 | -0.50% | 36,411 |
24-04-23 | 2.02 | +1.00% | 185,505 |
24-04-22 | 2 | +0.50% | 113,304 |
24-04-19 | 1.99 | +6.99% | 134,020 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.01% | 159M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.90% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- PRQR Stock